Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
OA04 - Mesothelioma Under the Looking Glass
- 14:30 - 15:30
- 8/07/2022
- Location: Hall C8
- Not for CME Credit
- Type: Oral
- Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies
- Moderators:Joachim G.J.V. Aerts, Anne Tsao
-
+
Session Moderator
15:02 - 15:12 | Presenter: Joachim G.J.V. Aerts
- Abstract
Loading... -
+
Session Moderator
15:02 - 15:12 | Presenter: Anne Tsao
- Abstract
Loading... -
+
OA04.01 - Session Introduction
14:30 - 14:31 | Presenter: Joachim G.J.V. Aerts
- Abstract
Loading... -
+
OA04.02 - Session Introduction
14:31 - 14:32 | Presenter: Anne Tsao
- Abstract
Loading... -
+
OA04.03 - Multi-omic Analysis of Malignant Pleural Mesothelioma PDXs Reveal Pathway Alterations and Therapeutic Targets
14:32 - 14:42 | Presenter: Triparna Sen
- Abstract
Loading... -
+
OA04.04 - Association of Novel microRNAs With Diagnosis and Histology of Malignant Pleural Mesothelioma
14:42 - 14:52 | Presenter: Michaela B Kirschner
- Abstract
Loading... -
+
OA04.05 - MESOMICS Project: Using Whole-Genome Sequencing Data to Fill the Gaps in Malignant Pleural Mesothelioma Molecular Studies
14:52 - 15:02 | Presenter: Nicolas Alcala
- Abstract
Loading... -
+
OA04.06 - PEMbrolizumab Plus Lenvatinib In Second And Third Line Malignant Pleural MEsotheLiomA Patients: A Single Arm Phase II Study (PEMMELA)
15:02 - 15:12 | Presenter: Li-Anne Huaqing Douma
- Abstract
Loading... -
+
OA04.07 - Discussant
15:12 - 15:22 | Presenter: Giovanni Luca Ceresoli
- Abstract
Loading... -
+
OA04.08 - Live Q&A
15:22 - 15:40
- Abstract
Loading...
-
+
EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
-
+
EP08.01-076 - KEYNOTE B36: A Pilot Study of First-line Tumor Treating Fields (150 kHz) Plus Pembrolizumab for Advanced or Metastatic Non-small Cell Lung Cancer
Presenter: Rupesh Kotecha- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
-
+
EP08.02-163 - Real-World Case Series on Efficacy and Safety of Amivantamab for EGFR-mutant Non-small Cell Lung Cancer
Presenter: Xiuning Le- Abstract
Loading...
